Physician profile
Celia Kolbach
NPI 1265847123
$2,154.80
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $949 · 2022: $929 · 2023: $142 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $640.13 | 2021-2024 | Omnipod |
| Abbott Laboratories | $455.50 | 2021-2024 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $394.72 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $350.01 | 2021-2022 | |
| Medtronic, INC. | $62.39 | 2021-2024 | Minimed 780g |
| Lifescan, INC. | $57.67 | 2021-2022 | |
| Dexcom, INC. | $51.98 | 2021 | |
| Zealand Pharma US, INC. | $41.29 | 2021 | |
| Sanofi-Aventis U.S. LLC | $33.00 | 2022 | |
| Lilly USA, LLC | $30.95 | 2021-2022 | |
| Becton, Dickinson and Company | $19.58 | 2022 | |
| Mannkind Corporation | $17.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celia Kolbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.